TD Asset Management Inc

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in SYRE

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$10,297,592

+$3,367,641 QoQ

Shares Held

115,990

-15.6% QoQ

Ownership

0.132%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#72

of 266 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,140,636,067 across 120 Biotechnology names. SYRE ranks #25 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,297,592	115,990	-15.6%	Shares	Sole	2026-08-04
2026-03-31	$6,929,951	137,390	-8.3%	Shares	Sole	2026-05-11
2025-12-31	$4,908,168	149,822	+107.0%	Shares	Sole	2026-02-10
2025-09-30	$1,212,887	72,368	-36.5%	Shares	Sole	2025-11-10
2025-06-30	$1,706,100	113,968	+409.5%	Shares	Sole	2025-07-28
2025-03-31	$360,907	22,368	-65.6%	Shares	Sole	2025-05-07
2024-12-31	$1,512,455	64,968	+23.1%	Shares	Sole	2025-02-11
2024-09-30	$1,551,906	52,768	+50.0%	Shares	Sole	2024-11-01
2024-06-30	$826,799	35,168	-42.3%	Shares	Sole	2024-08-02
2024-03-31	$2,312,516	60,968	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.